Honor Achieved Again! Star Biomedical Wins 2025 Talent Innovation and Entrepreneurship Leading Enterprise Award
On the afternoon of March 11, the 2026 Wuchang Street High-Quality Development Conference, themed "Galloping Forward on New Journeys, Creating the Future through Industry-City Integration," was successfully held. At the conference, Star Biomedical was honored with the "2025 Talent Innovation and Entrepreneurship Leading Enterprise" award in recognition of its innovative practices in talent team development, core technological innovation, and industry-university-research collaborative advancement. General Manager Zhao Hongshi attended the conference and accepted the award on stage.
As a biotechnology enterprise rooted in Wuchang Street, Star Biomedical has, since its establishment in 2010, consistently regarded talent as the core engine driving corporate innovation and development. The company strives to build a high-quality, specialized talent team, bringing together outstanding interdisciplinary talent from domestic prestigious universities in fields such as biology, materials science, and medicine. It has become a key participant and active promoter in the construction of Wuchang Street's talent innovation and entrepreneurship ecosystem.
Talent is the foundation of innovation, and demonstration embodies the power of leadership. Supported by its high-caliber talent team, Star Biomedical has continuously made strides in technological innovation, achieving a series of breakthrough results: The team focuses on the application of silk materials in human tissue repair, publishing a series of high-quality academic papers; establishing a medical-grade raw silk material base with end-to-end control from source to final product; independently designing, processing, and constructing a medical-grade raw silk material production line; leading or participating in drafting multiple industry standards, association standards, and international standards; continuously expanding the application scenarios of silk materials in the medical field; and steadily advancing the industrialization process of a series of silk fibroin-based regenerative medicine products.
In recent years, Wuchang Street has continuously optimized its business environment, innovatively launching the "Chang Ban Qi" service mechanism to build a broad platform for talent development within its jurisdiction. Star Biomedical's recognition as a "Talent Innovation and Entrepreneurship Leading Enterprise" signifies Wuchang Street's high acknowledgment of the company's talent management and innovation-driven development, as well as its high expectations for the company's future growth. To stimulate the innovative vitality of its talent, Star Biomedical closely integrates research achievements with personal development, encouraging its people to explore boldly and break new ground. Simultaneously, it has established an "industry-university-research-hospital" collaborative innovation platform, attracting outstanding graduates from universities, continuously consolidating the foundation for talent development, and enabling all kinds of talent to realize their value and achieve their dreams within the company's growth.
Nourished by the continuously improving innovation and entrepreneurship ecosystem in Yuhang District and Wuchang Street, Star Biomedical will strengthen its R&D investment, accelerate the pace of transforming scientific achievements, and actively integrate into the regional technological innovation system. At the same time, it will continuously improve its talent incentive mechanisms, fully stimulate the innovative and creative vitality of its talent, promote the technological iteration and upgrading of silk fibroin in the medical field, resonate with Wuchang Street, and jointly write a new chapter of industry-city integration and innovative development.
